Gyan Barik: First-In-Human Trial for Axana Stroke Detection Is Complete
Gyan Barik, Executive Director at Wellumio, shared Wellumio‘s post on LinkedIn, adding:
”Thrilled to share: Wellumio’s FIRST-IN-HUMAN trial for Axana stroke detection tech is COMPLETE at Royal Melbourne Hospital!
A game-changer for faster stroke decisions, huge thanks to participants, families, RMH teams (shoutout Dr James Barker, Amy MacDonald, Profs Geoffrey Donnan and Stephen Davis), and all partners.
Invaluable insights gained.
Phase 2, here we come!”
Quoting Wellumio‘s post:
”We’re very excited to announce the completion of our first-in-human clinical trial at The Royal Melbourne Hospital.
This is a major milestone and a significant step forward for Axana as we work to accelerate stroke detection and decision-making in time-critical settings.
First and foremost, we thank the study participants and their families.
This study would not have been possible without their generosity and willingness to support the advancement of medical technology.
We are also incredibly grateful to the clinicians, investigators, and research teams at RMH, along with all of our collaborators and partners who helped make this possible.
In particular, we’d like to acknowledge Dr James Barker and Amy MacDonald for coordinating the study day to day, and Professors Geoffrey Donnan and Stephen Davis from the Australian Stroke Alliance as the site Principal Investigators.
This trial has generated invaluable insights, and we’re looking forward to returning to the clinic for our Phase 2 trial.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 05:11Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
-
Sep 5, 2026, 04:56Opportunities for the Next Generation of Hematologists – American Society of Hematology
-
Sep 5, 2026, 04:51Samuel Nwokolo: The Bone Marrow Factory – Anatomy of Blood Production
-
Sep 5, 2026, 04:37Maryam Alaa Alsaid: Diagnostic Puzzle of Sickle Beta Thalassemia
-
Sep 5, 2026, 04:16Key Cardiovascular Insights from ESC Congress
-
Sep 5, 2026, 03:30Rob Maloney: Who Are the Real Experts? – The Quiet Resilience of the Bleeding Disorders Community
-
Sep 5, 2026, 03:26Project Elevate Her – Scaling Heights for Bleeding Disorders Awareness – WFH
-
Sep 5, 2026, 03:20Sarah Bassiony: How Do non-Specialists Learn Haematology? – Participate in Our Remote Study
-
Sep 5, 2026, 03:13Omid Seidizadeh: Uncovering the Genetic Architecture of Low Von Willebrand Factor